AAAAAA

   
Results: 1-11 |
Results: 11
IDENTIFICATION OF CYTOCHROME-P450 ISOFORMS INVOLVED IN FLUOXETINE N-DEMETHYLATION BY C-DNA EXPRESSED ENZYMES
Authors: VERBESSELT R TJANDRAMAGA TB DESCHEPPER PJ
Citation: R. Verbesselt et al., IDENTIFICATION OF CYTOCHROME-P450 ISOFORMS INVOLVED IN FLUOXETINE N-DEMETHYLATION BY C-DNA EXPRESSED ENZYMES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 439-439
MILD-TO-MODERATE HEPATIC INSUFFICIENCY DOES NOT AFFECT PHARMACOKINETICS AND PHARMACODYNAMICS OF TIROFIBAN
Authors: DEPRE M LO MW VANHECKEN A DELEPELEIRE I HAND EL LOWRY R CONNOR JG MURPHY MG FEVERY J DESCHEPPER PJ
Citation: M. Depre et al., MILD-TO-MODERATE HEPATIC INSUFFICIENCY DOES NOT AFFECT PHARMACOKINETICS AND PHARMACODYNAMICS OF TIROFIBAN, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4711-4711
PHARMACODYNAMICS AND PHARMACOKINETICS OF RWJ-53308, A NONPEPTIDE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, IN HEALTHY-MEN/
Authors: VANHECKEN A DEPRE M WYNANTS K ARNOUT J DOOSE D ABELS R VERCAMMEN E GIBSON D DESCHEPPER PJ
Citation: A. Vanhecken et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF RWJ-53308, A NONPEPTIDE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, IN HEALTHY-MEN/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4732-4732
LIQUID-CHROMATOGRAPHIC DETERMINATION OF TOTAL CELIPROLOL OR (S)-CELIPROLOL AND (R)-CELIPROLOL SIMULTANEOUSLY IN HUMAN PLASMA
Authors: VERBESSELT R ZUGRAVU A TJANDRAMAGA TB DESCHEPPER PJ
Citation: R. Verbesselt et al., LIQUID-CHROMATOGRAPHIC DETERMINATION OF TOTAL CELIPROLOL OR (S)-CELIPROLOL AND (R)-CELIPROLOL SIMULTANEOUSLY IN HUMAN PLASMA, Journal of chromatography B. Biomedical applications, 683(2), 1996, pp. 231-236
LACK OF A PHARMACOKINETIC INTERACTION BETWEEN MOEXIPRIL AND HYDROCHLOROTHIAZIDE
Authors: HUTT V MICHAELIS K VERBESSELT R DESCHEPPER PJ SALOMON P BONN R CAWELLO W ANGEHRN JC
Citation: V. Hutt et al., LACK OF A PHARMACOKINETIC INTERACTION BETWEEN MOEXIPRIL AND HYDROCHLOROTHIAZIDE, European Journal of Clinical Pharmacology, 51(3-4), 1996, pp. 339-344
EFFECT OF MK-386, A NOVEL INHIBITOR OF TYPE-1 5-ALPHA-REDUCTASE, ALONE AND IN COMBINATION WITH FINASTERIDE, ON SERUM DIHYDROTESTOSTERONE CONCENTRATIONS IN MEN
Authors: SCHWARTZ JI VANHECKEN A DESCHEPPER PJ DELEPELEIRE I LASSETER KC SHAMBLEN EC WINCHELL GA CONSTANZER ML CHAVEZ CM WANG DZ EBEL DL JUSTICE SJ GERTZ BJ
Citation: Ji. Schwartz et al., EFFECT OF MK-386, A NOVEL INHIBITOR OF TYPE-1 5-ALPHA-REDUCTASE, ALONE AND IN COMBINATION WITH FINASTERIDE, ON SERUM DIHYDROTESTOSTERONE CONCENTRATIONS IN MEN, The Journal of clinical endocrinology and metabolism, 81(8), 1996, pp. 2942-2947
HUMAN PHARMACOKINETICS AND TOLERABILITY OF L-697,639, A NONNUCLEOSIDEHIV-1 REVERSE-TRANSCRIPTASE INHIBITOR
Authors: VANHECKEN A DEPRE M DELEPELEIRE I LASKIN O AU T WOOLF E YEH KC DESCHEPPER PJ
Citation: A. Vanhecken et al., HUMAN PHARMACOKINETICS AND TOLERABILITY OF L-697,639, A NONNUCLEOSIDEHIV-1 REVERSE-TRANSCRIPTASE INHIBITOR, International journal of clinical pharmacology research, 14(2), 1994, pp. 45-50
PLASMA-CONCENTRATIONS AND EFFECT ON TESTOSTERONE-METABOLISM AFTER SINGLE DOSES OF MK-0434, A STEROID-5 ALPHA-REDUCTASE INHIBITOR, IN HEALTHY-SUBJECTS
Authors: VANHECKEN A DEPRE M SCHWARTZ JI TJANDRAMAGA TB WINCHELL GA DELEPELEIRE I NG J DESCHEPPER PJ
Citation: A. Vanhecken et al., PLASMA-CONCENTRATIONS AND EFFECT ON TESTOSTERONE-METABOLISM AFTER SINGLE DOSES OF MK-0434, A STEROID-5 ALPHA-REDUCTASE INHIBITOR, IN HEALTHY-SUBJECTS, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 123-126
PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ORAL DOSES OF MK-0591, A 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR
Authors: DEPRE M FRIEDMAN B VANHECKEN A DELEPELEIRE I TANAKA W DALLOB A SHINGO S PORRAS A LIN C DESCHEPPER PJ
Citation: M. Depre et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ORAL DOSES OF MK-0591, A 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 22-30
MOEXIPRIL DOES NOT ALTER THE PHARMACOKINETICS OR PHARMACODYNAMICS OF WARFARIN
Authors: VANHECKEN A VERBESSELT R DEPRE M TJANDRAMAGA TB ANGEHRN J CAWELLO W DESCHEPPER PJ
Citation: A. Vanhecken et al., MOEXIPRIL DOES NOT ALTER THE PHARMACOKINETICS OR PHARMACODYNAMICS OF WARFARIN, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 291-293
BIOCHEMICAL-ACTIVITY, PHARMACOKINETICS, AND TOLERABILITY OF MK-886, ALEUKOTRIENE BIOSYNTHESIS INHIBITOR, IN HUMANS
Authors: DEPRE M FRIEDMAN B TANAKA W VANHECKEN A BUNTINX A DESCHEPPER PJ
Citation: M. Depre et al., BIOCHEMICAL-ACTIVITY, PHARMACOKINETICS, AND TOLERABILITY OF MK-886, ALEUKOTRIENE BIOSYNTHESIS INHIBITOR, IN HUMANS, Clinical pharmacology and therapeutics, 53(5), 1993, pp. 602-607
Risultati: 1-11 |